Tiny study tests Super-Camera to spot retina damage early
NCT ID NCT05643157
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a new type of camera that can see individual cells in the retina, which standard clinical cameras cannot do. Five people with retinal disease (inherited degeneration or toxicity) had their eyes scanned with the device. The goal was to compare image quality and observe cell changes, not to treat any condition. It is a very early, small imaging study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this imaging method could help doctors see individual retina cells, leading to earlier detection and better monitoring of retinal diseases.
- What could go wrong
- This is a very small, early-stage imaging study with only 5 participants. It does not test any treatment, so it may not lead to direct patient benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Indiana University School of Optometry
Bloomington, Indiana, 47405, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New eye imaging could reveal hidden clues to vision loss
- A new eye camera may spot stressed cells before vision loss begins
- Gene therapy injection aims to halt blinding eye disease
- Eye imaging showdown: which device measures macular damage best?
- Bionic eye implant aims to bring back sight in advanced macular degeneration
- New cell therapy aims to slow vision loss in retinal disease